SecBot SecBot
8-K ·Filed Aug 31, 2026

QTI

QT IMAGING HOLDINGS, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago SEC0001628280-26-059577
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

This is a standard long-term incentive grant with no signal for near-term trading. Monitor the November 15, 2026 vest for any CEO share sales; otherwise, no action required.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
QTI ▼ -8.12% at T+20d
NEUTRAL call -8.12% · α vs SPY -8.44% · entry $2.77 → $2.55
Next anchor: T+60d in 28d
Latest observation: T+37 +8.22% FF3 residual α
Entry = T+0 close
Aug 31, 2026
via day close
T+1d
0.00%
call 0.00% · α -0.44%
$2.77
settled 8w ago
T+5d
-2.53%
call -2.53% · α -2.61%
$2.70
settled 7w ago
T+20d
-8.12%
call -8.12% · α -8.44%
$2.55
settled 28d ago
T+60d
Pending
in 28d

Price Chart

Loading chart...

Executive Summary

QT Imaging Holdings granted CEO Dr. Raluca Dinu 484,221 RSUs under the 2024 Amended and Restated Equity Incentive Plan. The award vests over approximately 3.4 years, with an initial tranche of ~90,791 RSUs vesting on November 15, 2026, and the remainder in quarterly installments through February 2030. This is a routine compensatory arrangement with no departure or unexpected executive change, and has no immediate financial or operational impact.

Key Facts

  • CEO Dr. Raluca Dinu received 484,221 RSUs approved by the Board on August 28, 2026.
  • Three-sixteenths (90,791 RSUs) vest on November 15, 2026; remaining 13/16ths vest in 13 equal quarterly installments through February 15, 2030.
  • Grant is under the company's 2024 Amended and Restated Equity Incentive Plan, subject to continued service.
  • No officer departures, resignations, or terminations were disclosed; the CEO remains in place.

Financial Impact

No immediate financial impact. The RSU grant will be recognized as non-cash compensation expense over the vesting period; the total expense is not disclosed on a per-vesting-date basis.

share count (dilutive upon vesting)compensation expense

Risk Factors

  • Dilution from RSU vesting over time, though moderate given the $45M market cap (484k shares ~1% dilution at current prices).
  • No operational or financial guidance change — this filing has zero bearing on revenue or earnings.

Market Snapshot

Exchange
OTC
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
83% bullish (6 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-059577
Document: 0001628280-26-059577-index-headers.html0001628280-26-059577
Document: 0001628280-26-059577-index.html0001628280-26-059577
Document: 0001628280-26-059577.txt0001628280-26-059577
4 reports for QTI
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for QTI — sortable, filterable
TypeNow
Aug 31, 2026
8w ago
8-K
NEUTRAL ★ 2/10
$2.77 $2.55▼ −8.12%▼ −8.44%$2.28 (−17.69%)
Aug 18, 2026
10w ago
8-K
BULLISH ★ 6/10
$2.91 $2.69▼ −7.56%▼ −6.57%$2.28 (−21.65%)
Jul 28, 2026
13w ago
8-K
NEUTRAL ★ 2/10
$2.71 $3.17▲ +16.97%▲ +11.95%$2.28 (−15.87%)
Feb 25, 2026
34w ago
8-K
BULLISH ★ 7/10
$5.50 $6.30▲ +14.55%▲ +20.96%$2.28 (−58.55%)
Showing 4 of 4

US Market Status

Market Closed — Opens Wed (15h 31m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 31, 2026